Ensysce Biosciences (ENSC) Current Taxes (2017 - 2020)
Ensysce Biosciences (ENSC) posted quarterly Current Taxes of $260404.0 for Q4 2020, down 90.6% year-over-year from $2.8 million in Q1 2020, and up 107.2% quarter-over-quarter from $125677.0 in Q3 2020.
Ensysce Biosciences (ENSC) Current Taxes (2017 - 2020) Analysis & Trends
Ensysce Biosciences (ENSC) has reported Current Taxes for 4 consecutive years, with $260404.0 the latest figure, recorded in Q4 2020.
- In Q4 2020, Current Taxes fell 90.6% year-over-year to $260404.0; the TTM figure through Dec 2020 stood at $260404.0 (down 90.6% YoY), while the FY2020 annual figure was $260404.0, down 90.6% from the prior year.
- Current Taxes advanced to $260404.0 in Q4 2020 per ENSC's latest filing, from $125677.0 in the prior quarter.
- Across five years, Current Taxes topped out at $2.8 million in Q4 2019 and bottomed at $339.0 in Q3 2018.
- Historically, Current Taxes has averaged $440580.4 across 4 years, with a median of $116750.0 in 2018.
- On a YoY basis, Current Taxes climbed as much as 5245.05% in 2020 and fell as far as 90.6% in 2020.
- Ensysce Biosciences' Current Taxes stood at $3635.0 in 2017, then sank by 90.67% to $339.0 in 2018, then jumped by 817311.5% to $2.8 million in 2019, then slumped by 90.6% to $260404.0 in 2020.
- Business Quant data shows ENSC's Current Taxes at $260404.0 in Q4 2020, $125677.0 in Q3 2020, and $629914.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.36 Mn |
| 10 | Ensysce Biosciences | 960,039.34 | -3.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 260,404.00 |
| Sep 30, 2020 | 125,677.00 |
| Jun 30, 2020 | 629,914.00 |
| Dec 31, 2019 | 2.77 Mn |
| Jun 30, 2019 | 11,785.00 |
| Mar 31, 2019 | 45,695.00 |
| Sep 30, 2018 | 339.00 |
| Mar 31, 2018 | 116,750.00 |
| Dec 31, 2017 | 3,635.00 |